About Sonovol

About company

Developer of a fully-automated benchtop ultrasound platform designed to lower the barrier of entry for every biologist that needs to perform preclinical screening or acquire longitudinal in vivo data in the pharmaceutical, biotech, government and academic markets. The company's platform permits researchers to rapidly determine tumor size, location, morphology and vascular density and the precise movement of the transducer through robotic motion control contributes to standardized results with every study, regardless of user, enabling researchers and clinicians to detect and treat tumor effectively.